iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Area of Science:

• Cardiology
• Global Health
• Evidence-Based Medicine

Background:

• Current heart failure (HF) guidelines face limitations in global applicability due to healthcare access inconsistencies, resource constraints, and diverse local practices.
• There is a critical need for universal recommendations that address the unique challenges in managing HF patients worldwide.

Purpose of the Study:

• To provide updated, evidence-based global implementation guidelines for heart failure (HF) management.
• To integrate novel therapies with standard of care and recent evidence to optimize patient outcomes.
• To offer context-specific recommendations, including strategies for resource-limited settings, to improve HF care globally.

Main Methods:

• Development of consensus-based recommendations by the iCARDIO Alliance.
• Comprehensive review of existing HF guidelines and recent evidence.
• Inclusion of "economic adjustment" recommendations for varying resource availability.

Main Results:

• The guidelines emphasize novel therapies and updated evidence for acute and chronic heart failure, including HF with reduced and preserved ejection fraction, and cardiomyopathies.
• Context-specific recommendations are provided, evaluating risks, benefits, and value of therapies.
• New recommendations address resource limitations, offering guidance for "somewhat limited" and "severely limited" resource scenarios.

Conclusions:

• These guidelines offer a unified, comprehensive, and concise strategy for the pharmacological, non-pharmacological, invasive, and interventional management of heart failure.
• The recommendations are designed to be applicable globally, improving patient outcomes and reducing hospitalization burden.
• The document provides crucial guidance for HF management in diverse healthcare settings worldwide.